YHB Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

YHB Investment Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$427K	Sell	817 -24	-3%	-$12.3K	0.03%	234
2026 Q2	$418K	Hold	841	–	–	0.03%	233
2026 Q1	$376K	Hold	841	–	–	0.03%	231
2025 Q4	$381K	Sell	841 -52	-6%	-$22.4K	0.03%	230
2025 Q3	$350K	Buy	893 +2	+0.2%	+$836	0.03%	239
2025 Q2	$397K	Sell	891 -50	-5%	-$23K	0.03%	226
2025 Q1	$456K	Buy	941 +100	+12%	+$46.6K	0.04%	211
2024 Q4	$339K	Buy	+841	New	+$390K	0.03%	222

Other funds holding VRTX

MSV

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

VWM

Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GGS

Galvin Gaustad & Stein Scottsdale, Arizona $1.33B AUM 13.15% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

LJHT

Laurie J. Hall Trustee $314M AUM 27.43% 1-Year Est. Return

CFG

Cooper Financial Group Irvine, California $1.26B AUM 21.18% 1-Year Est. Return

YHB Investment Advisors's VRTX Position: Q3 2026 in Review

YHB Investment Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 2.9% in Q3 2026, selling an estimated $12.3K and leaving 817 shares worth $427K. The position accounts for 0.03% of the portfolio, ranked #234.

YHB Investment Advisors first reported a position in VRTX in Q4 2024 and has held it in 8 quarters since. The position peaked at $456K in Q1 2025. 66 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

YHB Investment Advisors held 817 shares of Vertex Pharmaceuticals worth $427K as of Q3 2026.
YHB Investment Advisors sold 24 Vertex Pharmaceuticals shares in Q3 2026, an estimated $12.3K.
Vertex Pharmaceuticals made up 0.03% of YHB Investment Advisors's portfolio in Q3 2026, its #234 holding.
YHB Investment Advisors first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
YHB Investment Advisors's Vertex Pharmaceuticals position peaked at $456K in Q1 2025.
66 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on YHB Investment Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.